Clin2
NCT06851078Worth exploringNot yet recruiting

Early seizure medication for brain problems in septic shock

Septic Shock

Treatments studied

Part of Infections clinical trials.

This trial tests if giving an anti-seizure drug called levetiracetam early can help prevent or treat confusion and brain problems in people with septic shock. Septic shock is a life-threatening condition where an infection damages organs, sometimes affecting the brain.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
280 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older
  • You must be in the intensive care unit (ICU) for less than 4 days
  • You must have septic shock (a severe infection leading to very low blood pressure that started less than 24 hours ago)
  • You must not be on long-term seizure medication or have uncontrolled seizures
  • You cannot have certain severe brain conditions (like dementia or a recent major head injury)
  • You cannot be pregnant, breastfeeding, or have certain other medical conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07336992Not yet recruiting· Phase 3
Seizure prevention medicine for brain bleed recovery

This study tests whether a medicine called levetiracetam can help people recover better after a brain bleed. Half of the participants will receive the medicine, and half will receive a placebo. The goal is to see if this medicine can help improve recovery.

Bron
NCT06866691Recruiting· Phase 4
Seizure prevention after traumatic brain injury

This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.

Winston-Salem, North Carolina
NCT06773364Recruiting· Phase 3
Early levetiracetam and head position for stroke

This trial tests if starting a seizure medication called levetiracetam early in the ambulance, along with a specific head position, can help people having a stroke. It is for adults who show clear stroke signs within the last 2 hours and do not have other major health problems.

Suzhou, Anhui
NCT05610085Recruiting· Phase 2
Levetiracetam for newborn seizures: dose-finding study

This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.

San Diego, California
NCT07239115Recruiting· Phase 3
Levetiracetam to prevent seizures after brain tumor surgery

This trial tests whether the drug levetiracetam can prevent seizures in people who have brain tumor surgery. If you are having surgery to remove a brain tumor and have never had a seizure, this study may help keep you from having one after the operation.

Beijing
NCT07130786Recruiting· Phase 2
Preventing seizures with medication for brain tumors in movement area

This study tests whether giving a seizure medication (levetiracetam) to people with brain tumors in the movement area can prevent seizures. It compares taking the medication to not taking it, starting before any seizure occurs.

Boston, Massachusetts

Hear when a new Septic Shock trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.